SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: PHFR Pharmaceutical Formulations, Inc

No earlier versions found for this Subject.


Return to PHFR Pharmaceutical Formulations, Inc
 
Looking for some input...

< brief intro >

Pharmaceutical Formulations makes more than 120 types of generic drugs: pain relievers, cold and allergy medications, and antacids. The majority of its products are packaged under customers' own brand names, with less than 1% sold under the company's Health+Cross trade name. The firm sells to more than 50 retailers, largely drugstores, supermarkets, and mass merchandisers. Its largest customers include Revco/CVS (17% of sales), Walgreens (14% of sales), and Costco Wholesale (12% of sales). A sales force of 13 employees and 25 independent brokers markets Pharmaceutical Formulation's products nationwide.

Address: Pharmaceutical Formulations, Inc.
460 Plainfield Ave.
Edison, NJ 08818-1904
Phone: 732-985-7100
Fax: 732-819-3330

CEO: Charles E. LaRosa
CFO: Frank Marchese

shares outstanding - 30,228,320

float - 9,100,00

press releases:

Monday June 22, 10:48 am

Pharmaceutical Formulations, Inc. Receives Final FDA
Approval to Manufacture and Market Over-the-Counter
Cimetidine (national brand equivalent Tagamet(R)
HB(TM)200)

Wednesday June 3, 9:52 am

Pharmaceutical Formulations, Inc. Announces Plans to Sell
Store Brand OTC Pharmaceuticals in The United Kingdom